Blog: CENTURY THERAPEUTICS, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) – Marketscreener.com

Item 7.01 Regulation FD Disclosure

On June 13, 2022, Century Therapeutics, Inc. (the “Company”) updated information
reflected in a slide presentation, which is attached as Exhibit 99.1 to this
Current Report on Form 8-K and is incorporated herein by reference.
Representatives of the Company will use the updated presentation in various
meetings with investors from time to time.

The information contained in this Item 7.01 (including Exhibit 99.1) is being
furnished and shall not be deemed “filed” for purposes of Section 18 of the
Exchange Act, as amended (the “Exchange Act”), or otherwise subject to the
liabilities of that section and shall not be deemed to be incorporated by
reference in any filing under the Securities Act of 1933, as amended, or the
Exchange Act, except as shall be expressly set forth by specific reference in
such filing.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits

The following exhibit is being furnished herewith:

Exhibit
No.                                          Document

  99.1       Investor Presentation of Century Therapeutics, Inc., dated June 13, 2022

104        Cover Page Interactive Data File (embedded within the Inline XBRL document)

© Edgar Online, source Glimpses